Maxim Group is acting as manager. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on MYNZ: Mainz Biomed Highlights Growth and Innovations for 2025 Mainz Biomed restructured operations, implemented cost reductions Mainz Biomed reports 1H EPS (48c) vs. ($1.00) last year Mainz Biomed Sees Revenue Growth Amid Cost Reductions Mainz Biomed Secures Additional $1.5M Funding